Mark Stovsky, MD, MBA, FACS, Author at Grand Rounds in Urology

Mark Stovsky, MD, MBA, FACS

Cleveland Diagnostics

Cleveland, Ohio

Mark Stovsky, MD, MBA, FACS, is the Chief Medical Officer and Co-Founder of Cleveland Diagnostics in Cleveland, Ohio. Dr. Stovsky’s clinical expertise and research interests include the management of prostate cancer and benign prostate disease, diagnostic biomarkers for cancer and other diseases, and medical economics.

Dr. Stovsky earned his medical degree from Northwestern University in Chicago, Illinois. He earned his MBA from the University of Pittsburgh in Pennsylvania, where he was inducted into Beta Gamma Sigma. Dr. Stovksy then completed an internship in General Surgery and residencies in General Surgery and Urology, serving as Chief Urology Resident, at Case Western Reserve University in Cleveland, Ohio.

Dr. Stovksy is a Fellow of the American College of Surgeons. He currently serves on the board of the American Urological Association, North Central Section and for American Friends of Magen David Adom. He has also served as President of the North Central Section, the American Association of Clinical Urologists, the Cleveland Urological Society, and the Ohio Urological Society. Dr. Stovsky also served as a past board member of the Academy of Medicine of Cleveland/Northern Ohio Medical Association. Dr. Stovsky has also completed the American Urological Association’s Leadership Program.

Large-Scale, Prospective, Clinical Validation Study of the Diagnostic Performance of IsoPSA Without and in Combination with Multi-Parametric MRI for the Detection of High Grade Prostate Cancer

Mark Stovsky, MD, MBA, FACS | Dec 2025

Dr. Mark Stovsky presents prospective validation data showing IsoPSA improves detection of high-grade prostate cancer, both alone and with MRI.

Mark Stovsky, MD, MBA, FACS

Cleveland Diagnostics

Cleveland, Ohio

Talks by Mark Stovsky, MD, MBA, FACS

Large-Scale, Prospective, Clinical Validation Study of the Diagnostic Performance of IsoPSA Without and in Combination with Multi-Parametric MRI for the Detection of High Grade Prostate Cancer